Sign in
Not yet taking people in NetherlandsPhase 2

Tests geranylgeranylacetone to prevent heart rhythm problems after heart surgery

Tests geranylgeranylacetone to prevent atrial fibrillation in adults after heart surgery.

Key facts

Who runs it
Stichting Amsterdam UMC
Where
Amsterdam, NetherlandsSee the site
Trial code
Registry title
GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)
Status
Not yet recruiting
Phase
Phase 2
People taking part
146 people, planned
Started
1 Aug 2024
Planned end
1 Aug 2025
Type of study
Interventional
Record updated
21 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having heart surgery for a heart valve problem or coronary artery disease. It aims to prevent irregular heartbeat (atrial fibrillation) after surgery.

Age
18 to 80 years in the inclusion criteria; the registry lists 18 to 64 years.
Sex
All sexes can join.
Disease stage
Planned heart or chest surgery for mitral valve stenosis or regurgitation, and/or aortic valve stenosis or regurgitation, and/or coronary artery disease.
Earlier treatment
People who had earlier heart or chest surgery cannot join.

Main reasons for not taking part

  • Documented history of atrial fibrillation
  • Previous cardiothoracic surgery
  • Pre-menopausal women who are nursing, pregnant, or of child-bearing potential
  • Chronic malabsorption
  • Cancer or history of cancer within 1 year before screening, with two exceptions (treated basal cell carcinoma, in situ cervical carcinoma)

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Aged between 18 and 80 years old
  • Elected for cardiothoracic surgery for mitral valve stenosis or regurgitation, and/or aortic valve stenosis or regurgitation, and/or coronary artery disease

Who cannot take part

  • Previous cardiothoracic surgery
  • Currently enrolled in another drug trial
  • Documented history of AF
  • Any documented or suspected malignancy or history of malignancy within 1 year prior to screening, except appropriate treated basal cell carcinoma or in situ carcinoma of the cervix
  • Not able to undergo the complete study protocol
  • Doubt about compliance
  • Pre-menopausal women who are nursing, pregnant, or of child-bearing potential
  • Chronic malabsorption

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Netherlands

  • Stichting Amsterdam UMCAmsterdam, NetherlandsNot yet recruiting

About the trial

What the trial wants to find out

To prevent incidence of postoperative atrial fibrillation on patients undergoing cardiothoracic surgery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)
Plain-language title
Tests geranylgeranylacetone to prevent heart rhythm problems after heart surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2024-514743-28-00, who can take part
Record updated
21 January 2025